脑室出血增长:定义、患病率及其与血肿扩大和预后的关联
这项前瞻性观察研究纳入2011年7月至2017年3月一家三级医院的303例脑出血患者,要求症状出现6小时内完成基线CT、36小时内完成随访CT。脑室出血增长定义为基线无脑室出血者随访CT出现新发脑室出血,或基线有脑室出血者随访CT脑室出血体积增加≥1 mL。59例(19.5%)出现脑室出血增长,这些患者基线血肿体积更大、NIHSS评分更高、GCS评分更低。多变量分析显示脑室出血增长是3个月不良功能结局(mRS 3-6)的独立预测因素(调整OR 4.15,95%CI 1.31-13.20;P=0.016)。
要点
- 脑室出血增长定义为:基线无脑室出血者随访CT新发脑室出血,或基线有脑室出血者随访CT脑室出血体积增加≥1 mL。
- 303例脑出血患者中59例(19.5%)出现脑室出血增长。
- 脑室出血增长患者基线血肿体积更大、NIHSS评分更高、GCS评分更低。
- 脑室出血增长独立预测3个月不良功能结局(mRS 3-6),调整OR 4.15(95%CI 1.31-13.20;P=0.016)。
- 44例同时出现脑室出血增长和血肿增长的患者中,41例(93.2%)3个月随访时功能结局不良。
适用人群与场景
- 脑出血患者,症状出现6小时内完成基线CT、36小时内完成随访CT,来自一家三级医院的前瞻性观察研究。
诊断标准与关键阈值
- 脑室出血增长:基线无脑室出血者随访CT出现新发脑室出血,或基线有脑室出血者随访CT脑室出血体积增加≥1 mL。
- 不良功能结局:90天改良Rankin量表评分3-6分。
研究设计与关键结果
- 前瞻性观察研究,纳入303例脑出血患者,脑室出血增长59例(19.5%)。
- 脑室出血增长患者较无增长者基线血肿体积更大、NIHSS评分更高、GCS评分更低。
- 44例同时出现脑室出血增长和血肿增长的患者中,41例(93.2%)3个月随访功能结局不良。
- 多变量分析显示脑室出血增长是3个月不良功能结局(mRS 3-6)的独立预测因素(调整OR 4.15,95%CI 1.31-13.20;P=0.016)。
证据类型、等级与局限
- 证据类型:前瞻性观察研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为脑室出血增长并不少见,独立预测脑出血患者不良结局,可能作为有前景的治疗干预靶点。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND/OBJECTIVES: The objective of this study is to propose a definition of intraventricular hemorrhage (IVH) growth and to investigate whether IVH growth is associated with ICH expansion and functional outcome.
METHODS: We performed a prospective observational study of ICH patients between July 2011 and March 2017 in a tertiary hospital. Patients were included if they had a baseline CT scan within 6 h after onset of symptoms and a follow-up CT within 36 h. IVH growth was defined as either any newly occurring intraventricular bleeding on follow-up CT scan in patients without baseline IVH or an increase in IVH volume ≥ 1 mL on follow-up CT scan in patients with initial IVH. Poor outcome was defined as modified Rankin Scale score of 3-6 at 90 days. The association between IVH growth and functional outcome was assessed by using multivariable logistic regression analysis.
RESULTS: IVH growth was observed in 59 (19.5%) of 303 patients. Patients with IVH growth had larger baseline hematoma volume, higher NIHSS score and lower GCS score than those without. Of 44 patients who had concurrent IVH growth and hematoma growth, 41 (93.2%) had poor functional outcome at 3-month follow-up. IVH growth (adjusted OR 4.15, 95% CI 1.31-13.20; P = 0.016) was an independent predictor of poor functional outcome (mRS 3-6) at 3 months in multivariable analysis.
CONCLUSION: IVH growth is not uncommon and independently predicts poor outcome in ICH patients. It may serve as a promising therapeutic target for intervention.
参考来源
- Li Q, Li R, Zhao LB, et al. Intraventricular Hemorrhage Growth: Definition, Prevalence and Association with Hematoma Expansion and Prognosis. Neurocrit Care. 2020. PMID: 32219678. doi:10.1007/s12028-020-00958-8
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。